Tag results:
lymphocytes
Cancer Stem Cell News
A Novel CD34-Specific T-cell Engager Efficiently Depletes Acute Myeloid Leukemia and Leukemic Stem Cells In Vitro and In Vivo
[Haematologica] Researchers designed a CD34/CD3 bispecific T-cell engager (BiTE) and characterized its anti-leukemia potential in vitro, ex vivo and in vivo.
Immunology of Infectious Disease News
Viral PB1-F2 and Host IFN-γ Guide ILC2 and T Cell Activity during Influenza Virus Infection
[Proceedings of the National Academy of Sciences of the United States of America] In the absence of IFN-γ, lung innate lymphoid cells (ILC12) from mice challenged with the A/California/04/2009 H1N1 virus, containing nonfunctional viral PB1-F2, initiated a robust IL-5 response, which also led to improved tissue integrity and increased survival.
Immune Regulation News
Themis Is Indispensable for IL-2 and IL-15 Signaling in T Cells
[Science Signaling] The authors investigated whether Themis plays a direct role in cytokine signaling in mature T cells.
Extracellular Matrix News
Force Generation Machinery Is Exploited by Cancer Cells Promoting Tumor Progression via ECM Remodeling and Immunosuppression
[Biophysical Journal] Researchers found that in addition to increased cell motility, cancer cells exploited the elevated actomyosin force generation to remodel ECM and to deplete important co-stimulatory receptors on antigen presenting cells, facilitating tumor progression.
Hematopoiesis News
The PAX5-JAK2 Translocation Acts as Dual-Hit Mutation That Promotes Aggressive B Cell Leukemia via Nuclear STAT5 Activation
[EMBO Journal] Researchers revealed Pax5-Jak2 as an important nuclear driver of leukemogenesis by maintaining phosphorylated STAT5 levels in the nucleus.
Immunology of Infectious Disease News
IL-22 Initiates an IL-18-Dependent Epithelial Response Circuit to Enforce Intestinal Host Defence
[Nature Communications] Scientists showed that IL-18 was a bona fide IL-22-regulated gate keeper for intestinal epithelial barrier.